Search PDMR transactions

Notifier
Name of person with notification obligation
Mark Beveridge
Reason for notification
Closely associated
No
Person discharging managerial responsibilities
Mark Beveridge
Position
Chief Financial Officer (CFO)
Initial notification
Yes
Amendment
No
Details of amendment
Details of the Issuer/emission allowance market participant/auction platform/auctioneer/auction monitor
Name of issuer
Moberg Pharma AB
Issuer´s LEI code
549300XFXK7DVGDRP410
Details of transaction
Type of financial instrument Financial instrument ISIN code Nature of transaction Linked to the exercise of a share option programme Volume Unit Price per unit Currency code Transaction date Place of the transaction
Share Moberg Pharma AB SE0013121340 Acquisition 5,000 Quantity 5.96 SEK 09/11/2021 NASDAQ STOCKHOLM AB
Share Moberg Pharma AB SE0013121340 Acquisition 3,000 Quantity 5.77 SEK 10/11/2021 NASDAQ STOCKHOLM AB
Share Moberg Pharma AB SE0013121340 Acquisition 3,000 Quantity 5.91 SEK 11/11/2021 NASDAQ STOCKHOLM AB
Aggregation
Financial instrument ISIN code Nature of transaction Transaction date Place of the transaction Volume Weighted average price
Moberg Pharma AB SE0013121340 Acquisition 09/11/2021 NASDAQ STOCKHOLM AB 5,000 (Quantity) 5.96 SEK
Moberg Pharma AB SE0013121340 Acquisition 10/11/2021 NASDAQ STOCKHOLM AB 3,000 (Quantity) 5.77 SEK
Moberg Pharma AB SE0013121340 Acquisition 11/11/2021 NASDAQ STOCKHOLM AB 3,000 (Quantity) 5.91 SEK
Total: 11,000
<< Back